The study identifies and characterizes several efflux pump genes (norA, mepA, bmrA, patA, and patB) in Gram-positive bacteria, demonstrating their role in mediating resistance to fluoroquinolones. A novel diagnostic molecule, 5a4, was developed to quantify efflux activity, showing promise for rapid and accurate detection of efflux-mediated resistance.